TELADOC HEALTH INC (TDOC)
Health Care · digital health / telehealth · NYSE
A global leader in virtual care services, connecting patients to providers for a wide range of medical, specialty, and chronic condition management needs.
What TELADOC HEALTH INC does
Teladoc Health is a global virtual healthcare company that provides a comprehensive platform for clinical care. The company offers virtual medical services, including general medical care, specialty care, chronic condition management, and mental health services, directly to consumers, employers, and health plans.
Themes: telehealth, digital health platform, virtual care, chronic disease management, mental health services
Fundamentals
- Price$6.39 as of 2026-08-21 close
- Market cap$1.2B as of 2026-08-21
- 1-year return-11.1% 2025-08-21 close $7.19 → 2026-08-21 close $6.39
- P/En/a negative earnings
- Net margin-7.1% as of 2026-08-24
- Gross margin+69.0% as of 2026-08-24
- ROE-13.1% as of 2026-08-24
- Debt / equity0.76 as of 2026-08-24
- Revenue growth (YoY)-2.1% as of 2026-08-24
- Revenue CAGR (3y)+1.7% SEC XBRL
- Beta2.14 as of 2026-08-24
- Last reported earnings2026-07-29 SEC EDGAR Form 8-K (Item 2.02)
How TDOC compares in its sector
- net profit marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- operating marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- gross marginmiddle range 384 covered Health Care peers, as of 2026-08-24
- return on equitymiddle range 576 covered Health Care peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)top 25% 493 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
How TELADOC HEALTH INC looks technically
TELADOC HEALTH INC (TDOC) is trading 5.4% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average crossed above its 200-day average about 39 trading days ago — a "golden cross", a bullish long-term signal. A strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 30, with sellers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 36, neither overbought (above 70) nor oversold (below 30). It just made a new 20-day low, its first since 2026-05-18, breaking below its recent trading range. It is 35.4% below its highest point of the past year.
Trend
8
| Distance from the 200-day | it is trading 5.4% below its 200-day average, the long-term trend line — a long-term downtrend | -5.4% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $8.03 | $8.03 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $6.76 | $6.76 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 14 calendar days ago — the swings before that are what the structure reading is measured on | 14 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes above 7.235. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible downward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 39 trading days ago — a "golden cross", a bullish long-term signal | 39 sessions |
| Trend strength (14-day ADX) | a strong downtrend is in place — ADX, a 0–100 trend-strength gauge, is 30, with sellers in control | 29.5 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 36, neither overbought (above 70) nor oversold (below 30) | 35.9 |
|---|---|---|
| Position in its 14-day range | it is trading right at the bottom of its 14-day range ($6.35 to $7.24) — its "stochastic" reading is 5 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 4.5 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in negative territory (momentum leaning bearish) | 26 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $9.89 | $9.89 |
|---|---|---|
| From the 52-week high | it is 35.4% below its 52-week high (its highest price of the past year) | -35.4% |
| Above the 52-week low | it is 45.2% above its 52-week low (its lowest price of the past year) | +45.2% |
| Below the 52-week high | it is 35.4% below its highest point of the past year | 35.4% |
| Since a 20-day breakout | it just made a new 20-day low, its first since 2026-05-18, breaking below its recent trading range | 1 session |
| Since a 55-day breakout | it just made a new 55-day low, its first since 2026-05-18, breaking below its recent trading range | 1 session |
| All-time high | its highest closing price on record is $308.00 (set on 2021-02-16) | $308.00 |
| Given back of the 52-week move | over the past year its closes ranged ($4.47 to $9.72), and it has given back close to two thirds of its rise from last year’s low — 63% of it. Chart-watchers call 61.8%-65% given back the "golden pocket", and this is inside it — for this company that is $6.31 to $6.48. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 63.4% |
| From the all-time high | it is 97.9% below its all-time high | -97.9% |
| Nearest price level | it is trading 0.6% above a support level at $6.35 — a price it turned at twice since 2025-04-21, most recently on 2026-07-31. Since 2024-08-21 it has 3 such levels below the current price and 13 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -0.6% |
| All-time low | its lowest closing price on record is $4.40 (set on 2026-02-12) | $4.40 |
| Above the all-time low | it is 45.2% above its all-time low | +45.2% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually wide versus its own recent history (wider than about 90% of the past ~6 months) | 90th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.3881 between its high and its low — about 6.1% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.3881 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $5.31 and $8.87 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $5.31 – $7.09 – $8.87 |
| Typical daily range (% of price) | its price moves about 6.1% in a typical session — more volatile than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 6.1% |
| Stretch from the 200-day average | it is trading 1.0 daily range below its 200-day average price (5.4% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 1.0 daily range below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.67× |
|---|
Analyst
2
| Change in the average price target | analysts have cut their average price target by 0.7% since the prior reading | -0.7% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Price gaps
2
| Gap at the open | it opened on 2026-08-21 0.2% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.1% |
|---|---|---|
| Gap filled | a 2.1% gap up opened on 2026-07-27 has been "filled" 19 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 19 sessions ago |
Price streaks
1
| Closing streak | it has closed lower 2 sessions in a row, a -4.05% move over the run — an unbroken run of down days, which describes what has already happened and says nothing about the next session | 2 sessions down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 36.5 percentage points (the stock lost 34.2% while the market gained 2.3%) | -36.5% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 5.8 percentage points (the stock lost 2.7% while the market gained 3.1%) | -5.8% |
| vs market, 6 months | over the past 6 months this stock beat the market by 23.7 percentage points (the stock gained 34.8% while the market gained 11.1%) | +23.7% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 31.6 percentage points (the stock lost 11.1% while the market gained 20.5%) | -31.6% |
Signal agreement
2
| Bullish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, outperforming the market over 6 months, near the bottom of its 14-day range (oversold) — these describe past price behaviour, not a forecast | 3 of 9 |
|---|---|---|
| Bearish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bearish state: a strong downtrend, with sellers in control, trading below its 200-day average, a fresh 20-day low, MACD momentum is negative, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 5 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 15% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is thick, spanning 20.8% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | -15.5% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 1% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $6.46 — a volume-weighted average of daily closes over 158 sessions, not a true tick-by-tick VWAP. | -1.1% |
|---|---|---|
| Vs the average paid since it last reported | the price is 7% below the average price paid since it last reported on 2026-07-29 (its 8-K), so the typical buyer over that stretch is under water. That average is $6.89 — a volume-weighted average of daily closes over 18 sessions, not a true tick-by-tick VWAP. | -7.3% |
Price levels it has turned at before
TDOC last closed at $6.39 on 2026-08-21. Since 2024-08-21 it has turned at 3 prices below its last close and 13 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $6.35 | Support | 0.6% below the last close | turned there twice · 2025-04-21 to 2026-07-31 |
| $6.25 | Support | 2.2% below the last close | turned there twice · 2026-04-21 to 2026-05-15 |
| $6.64 | Resistance | 3.9% above the last close | turned there five times · 2025-04-07 to 2025-11-17 |
| $6.76 | Resistance | 5.8% above the last close | turned there twice · 2024-08-28 to 2025-08-12 |
| $6.87 | Resistance | 7.5% above the last close | turned there twice · 2025-12-29 to 2026-06-11 |
| $5.65 | Support | 11.6% below the last close | turned there twice · 2026-03-25 to 2026-04-08 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes above $7.24.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $1.51 and $3.70 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close above $7.24.
This reading has stood for 6 trading days, since 2026-08-14.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Pulled back from the 12-month high · Broke down to a new 20-day low · beating the market · Most volatile (6%+ typical daily range) · At the bottom of its 14-day range (stochastic below 20) | Learn: moving average · golden cross · adx · rsi · breakout · fifty two week high low
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingHold (2.54 mean, 1=Strong Buy…5=Strong Sell) — 19 analysts
- Mean price target$7.74 range $5.50 – $10.50; median $7.50
Analyst estimates, as of 2026-08-17. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for TDOC
- Consensus EPS estimate-$0.205 next reporting period, as of 2026-08-17
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Ongoing operating losses and significant accumulated deficit.","High competitive intensity in the virtual care and digital health market.","Dependency on retaining and growing membership and utilization rates among existing health plan and employer clients."]
What changed in the latest 10-Q
AI-assisted comparison of TDOC's 10-Q filed 2026-04-30 against the prior one filed 2025-10-30.
Management's Discussion & Analysis (MD&A)
- Added:
- Added new paragraph in Overview section beginning with 'More than 20 years ago, we were founded on a simple, yet revolutionary idea...' (filed 2026-04-30)
- Added new paragraph in Overview section: 'Our mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. Today, we are transforming virtual care into a catalyst for how better health happens around the world. We connect patients, care providers, healthcare platforms and partners to provide more complete and personalized care. Through our unique technology, breadth of services and depth of clinical expertise, we are delivering and orchestrating care in order to improve health outcomes and reduce healthcare costs around the world.' (filed 2026-04-30)
- Removed:
- Removed phrase 'focused on forging a new healthcare experience with better convenience, outcomes, and value around the world' from the sentence 'Teladoc Health is the global leader in virtual care' (filed 2025-10-30)
- Removed paragraph: 'We were founded on a simple, yet revolutionary idea: that everyone should have access to the best healthcare, anywhere in the world on their terms. Today, we have a vision of making virtual care the first step on any healthcare journey, and we are delivering on this mission by providing virtual care that includes primary care, mental health, chronic condition management, and more.' (filed 2025-10-30)
- Reworded:
- Changed reference from '2024 Form 10-K' to '2025 Form 10-K' in forward-looking statements section (filed 2026-04-30)
- Changed 'virtual healthcare devices' to 'virtual care devices' in tariffs discussion (filed 2026-04-30)
- Changed 'hosted virtual healthcare platform solution' to 'hosted virtual care platform solution' in tariffs discussion (filed 2026-04-30)
- Changed 'Individuals who have paid access fees offer a greater margin than those who have visit fee only arrangements and, over time, the mix of those who have paid access fees as compared to those who have visit fee only arrangements' to 'Individuals who have paid access offer a greater margin than those who have visit fee only access and, over time, the mix of those who have paid access as compared to those who have visit fee only access' (filed 2026-04-30)
- Changed 'which could result in a loss' to 'which could result in a loss of members.' with complete sentence in newer filing (filed 2026-04-30)
- Notes:
- The older filing text appears truncated at the end of the 'Key Factors Affecting Our Performance' section, making complete comparison of that section not fully assessable
- The comparison reflects changes in the MD&A section as presented; both filings show different fiscal period ends (2026-03-31 vs 2025-09-30)
Risk Factors
The two filings could not be meaningfully compared for this section.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
0 open-market purchases and 12 open-market sales by insiders in the last 90 days.
- Last 90 days0 buys · 12 sells ($627253) — 6 selling insiders
- Last 180 days0 buys · 13 sells ($630705) — 6 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-07-06. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about TDOC's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
6 institutional 13F filers reported holding TDOC as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 6
- Reported shares held 29,028,495
- Reported value $158,205,300
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 3 increased, 3 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
TDOC had 26,303,828 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
TDOC had 14.5% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 3.96 days to cover at the same settlement.
- Reported short interest (shares) 26,303,828
- Short interest (% of shares outstanding) 14.5%
- Prior settlement (shares) 28,060,519
- Reported change -6.26%
- Days to cover (reported) 3.96
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Amwell (AMWL)
- Hims & Hers Health (HIMS)
- Doctor On Demand
- MDLIVE
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare TDOC vs…
TELADOC HEALTH INC is found in…
TDOC ranks in…
Frequently asked questions
What does TELADOC HEALTH INC (TDOC) do?
Teladoc Health is a global virtual healthcare company that provides a comprehensive platform for clinical care. The company offers virtual medical services, including general medical care, specialty care, chronic condition management, and mental health services, directly to consumers, employers, and health plans.
What sector is TELADOC HEALTH INC (TDOC) in?
TELADOC HEALTH INC (TDOC) is classified in the Health Care sector. Its industry is digital health / telehealth. It trades on NYSE.
Who are TELADOC HEALTH INC's (TDOC) competitors?
Notable peers of TELADOC HEALTH INC (TDOC) include Amwell, Hims & Hers Health, Doctor On Demand and MDLIVE. This peer set is informational only — not financial advice.
Is TELADOC HEALTH INC (TDOC) overbought or oversold right now?
TELADOC HEALTH INC (TDOC) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 36, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on TDOC come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.